Effect of a combined treatment with erythropoietin and melatonin on renal ischemia reperfusion injury in male rats
- 332 Downloads
Renal ischemia reperfusion (IR) is an important cause of renal dysfunction. It contributes to the development of acute renal failure. Oxidative damage from reactive oxygen species is considered to be the principal component involved in the pathophysiological tissue alterations observed during IR. The purpose of this study was to evaluate the effect of a combined treatment with erythropoietin (EPO) plus melatonin (MEL), which are known anti-inflammatory and antioxidant agents, in IR-induced renal injury in rats.
Wistar Albino rats were unilaterally nephrectomized and subjected to 45 min of renal pedicle occlusion followed by 24 h of reperfusion. MEL (10 mg/kg, i.p) and EPO (5000 U/kg, i.p) were administered prior to ischemia. After 24 h of reperfusion, blood samples were collected for the determination of superoxide dismutase (SOD), glutathione peroxidase (GPx), plasma levels of total antioxidant capacity (TAC), and malondialdehyde (MDA) and serum urea level. Also, renal samples were taken for histological evaluation.
Ischemia reperfusion significantly increased urea, blood SOD, and GPx levels. Histological findings of the IR group indicated that there was increase in tubular and glomerular hyaline cast, thickening of Bowman capsule basement membrane, and renal impairment in the glomerular epithelium. Treatment with EPO and MEL significantly decreased blood SOD, GPx, and urea levels and increased TAC level. In the EPO + MEL group, while the histopathological changes were lower than those in EPO group, they were the same as MEL group.
EPO and MEL combination treatment exerted more nephroprotective effects than EPO treatment and nearly had protective effects similar to MEL treatment.
KeywordsIschemia reperfusion injury Antioxidants Melatonin Erythropoietin Kidney
This study was financially supported by Drug Applied Research Center of Tabriz University of Medical Sciences.
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Singh D, Chander V, Chopra K. Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmocal Rep. 2005;57:70–6.Google Scholar
- 12.Benjamin B, Ebert L, Bunn HF. Regulation of erythropoietin gene. Blood. 1999;94:1864–77.Google Scholar
- 16.Calo LA, Bertipaglia L, Pagnin E. Antioxidants, carnitine and erythropoietin. G Ital Nefrol. 2006;34:47–50.Google Scholar
- 22.Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Warden LR. Melatonin: a highly potent endogenous radical scavenger and electron donor new aspects of the oxidation chemistry of this indole accessed in vitro. Ann NY Acad Sci. 1994;17:419–29.Google Scholar
- 25.Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J. 1993;1:57–60.Google Scholar
- 47.Kiris I, Okutan H, Savas C, Yönden Z, Delibaş N. Deneysel aortic iskemi-reperfuzyon modelinde renal hasara gadolinium klorurun etkisi.Turkish. J Vasc Surg. 2005;14:13–8.Google Scholar
- 51.Dimitrijevic ZM, Cvetkovic TP, Djordjevic VM, Pavlovic DD, Stefanovic NZ, Stojanovic IR, Paunovic GJ, Velickovic-Radovanovic RM. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients. Int J Med Sci. 2012;9(9):808–15.PubMedCentralPubMedCrossRefGoogle Scholar
- 54.Paller MS. Pathophysiologic mechanisms of acute renal failure. In: Goldstein RS, editor. Mechanisms of injury in renal disease and toxicity. Michigan: Ann Arbor CRC Press; 1994. p. 3–13.Google Scholar
- 61.Li Z, Nickkholgh A, Yi X, Bruns H, Gross ML, Hoffmann K, Mohr E, Zorn M, Büchler MW, Schemmer P. Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res. 2009;46:365–72.PubMedCrossRefGoogle Scholar
- 62.Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, Kieswich J, Allen D, Harwood S, Raftery M, Thiemermann C, Yaqoob MM. Erythropoietin protects he kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004;15:2115–24.PubMedCrossRefGoogle Scholar